PrimeRFP SCOUT · Federal Contract Recompete Brief

36C10X21F001865 VII invitro diagnostics reagents TEST — Abbott Rapid Dx North America, LLC

Abbott Rapid Dx North America, LLC holds $42.8M across 9,132 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 4 related awards under parent 36F79721D0073. The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Jan 7, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Sac Frederick (36C10X)
Awarding office
Abbott Rapid Dx North America, LLC
Recipient
Jan 7, 2022
PoP end
$9.6M
Obligated
$14.9M
Potential
325413
NAICS
6550
PSC
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Abbott Rapid Dx North America, LLC — $90

Contract facts

Federal
Contract number36C10X21F0018
Also listed as36C10X-21-F-0018
Also listed as36F79721D0073-36C10X21F0018
AgencySac Frederick (36C10X)
Awarding officeSac Frederick (36C10X)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentAbbott Rapid Dx North America, LLC
CAGE5C4F2
UEIP782RNU1NNK3
NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6550
Parent IDIQ / IDV36F79721D0073
Place of performanceORLANDO FL
Pricing typeFixed Price With Economic Price Adjustment
Extent competedFull And Open Competition
PoP startJan 8, 2021
PoP end (current)Jan 7, 2022
Obligated$9.6M
Current value$14.9M
Potential value$14.9M

65 VII, INVITRO DIAGNOSTICS, REAGENTS, TEST KITS, & TEST SETS, FSS CONTRACT AWARD is a federal award for Sac Frederick (36C10X) held by Abbott Rapid Dx North America, LLC. Estimated value $14.9M ($9.6M obligated). Current period of performance ends Jan 7, 2022. Last award drew 1 bidder. Place of performance: ORLANDO FL.

65 VII, INVITRO DIAGNOSTICS, REAGENTS, TEST KITS, & TEST SETS, FSS CONTRACT AWARD

Recompete timing

Public
Past PoP end (1687 days ago)

Current PoP ended Jan 7, 2022 (1687 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Abbott Rapid Dx North America, LLC$42.8M obligated across 9,132 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($42.8M) · all agencies · Top 2 shown (11%); remaining ~89% is other agencies.
Department of Defense (DOD)$4.4M · 10%Department of State (DOS)$368K · 1%
Open full company profile

Related awards

Same parent · incumbent
36C25921C0054
SOFTWARE LICENSES AND MONITORING FOR THE INTERFACE OF CEPHEID AND ABBOTT ANALYZERS
$438K
Aug 31, 2026
36C24126N0170
BINAXNOW TESTING SUPPLIES
$123K
Dec 31, 2026
36C25523N0120
COVID-19 ANTIGEN TESTING
$249K
Jan 31, 2027
36C24422F0471
BINAXNOW COVID TEST KITS
$422K
Jul 31, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C10X21F0018?

36C10X21F0018 (65 VII invitro diagnostics reagents TEST) is a Sac Frederick (36C10X) award with a potential value of $14.9M, currently held by Abbott Rapid Dx North America, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C10X-21-F-0018?

36C10X-21-F-0018 is the dashed form of PIID 36C10X21F0018 (65 VII invitro diagnostics reagents TEST), held by Abbott Rapid Dx North America, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C10X21F0018?

Sac Frederick (36C10X) awarded 36C10X21F0018 to Abbott Rapid Dx North America, LLC (potential $14.9M).

Who is the incumbent on 36C10X21F0018?

Abbott Rapid Dx North America, LLC is the incumbent with $42.8M across 9132 related awards in SCOUT’s public footprint. The current period of performance ends Jan 7, 2022.

When does Abbott Rapid Dx North America, LLC’s 36C10X21F0018 come up for recompete?

SCOUT tracks a period-of-performance end of Jan 7, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C10X21F0018